Cardiex receives pre-orders for CONNEQT vascular monitor

Health technology developer Cardiex has begun to receive pre-orders in the United States for its CONNEQT Arterial Health Assessment, which comes complete with the CONNEQT Pulse vascular biometric monitor (pictured).

Following a successful waitlist and nurturing of the 20,000 sign-ups for Pulse, exclusive invitations for pre-orders have now commenced, according to the company.

The milestone marks the first phase of the company’s transition to delivering transformative cardiovascular solutions, based on CONNEQT Pulse’s capability to deliver precise blood pressure measurements.

Cardiex CEO Craig Cooper said: “This is a pivotal moment for the company as we launch the CONNEQT Pulse, bringing our vascular health technology directly to US consumers for the first time.

“This phased pre-order rollout allows us to ensure a smooth customer experience while efficiently managing demand and conversions.

“Reaching this milestone reaffirms the strength of our strategy, and we expect the positive momentum to support revenue growth and accelerate our entry into broader healthcare markets.”

CONNEQT Pulse is designed to meet rising demand for cardiovascular health monitoring solutions that go beyond traditional blood pressure measurement.

The device incorporates additional vascular biomarkers such as measurements of arterial stiffness and early vascular ageing, enabling early detection and proactive management of cardiovascular risks.

“With its focus on accessible, personalised health insights, the Pulse is set to become a valuable tool for individuals seeking proactive cardiovascular health management and for clinicians looking to enhance patient care with advanced vascular health metrics.

“Cardiex will continue to roll out additional waves of exclusive pre-order invitations to waitlist members over the coming weeks.”

Browse @AuManufacturing’s coverage of Cardiex here.

Picture: CONNEQT Pulse